$ cat molecule-index.md
# Molecule Index
> Same ingredient. Different brand. Different country. Different price.
Source-backed medicine price notes for the drugs we can verify now; ingredient-first index for the rest.
Emtricitabine, Ril o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate
Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate · Oral
Rilpivirine o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Rilpivirine
Rilpivirine · Oral
Emtricitabine, Ril o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Odefsey
Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Alafenamide · Oral
Cabotegravir And R o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Cabenuva Kit
Cabotegravir And Rilpivirine · Oral
Dolutegravir Sodiu o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Juluca
Dolutegravir Sodium And Rilpivirine Hydrochloride · Oral
Rilpivirine Hydroc o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Edurant , Edurant Ped (Rilpivirine Hydrochloride) Tablet, For
Rilpivirine Hydrochloride · Oral
Emtricitabine, Ril o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Complera
Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate · Oral
Emtricitabine, Ril o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Complera Access
Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate · Oral
Emtricitabine, Ril o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate
Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate · Oral
Emtricitabine, Ril o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Odefsey
Emtricitabine, Rilpivirine, And Tenofovir Alafenamide · Oral
$ cat method.md
Ingredient first, prices second
Now
Index 100,000 drug/package records by active ingredient, brand, route, class hint, source, and risk/price-gap watch signals.
Next
Attach daily country snapshots for US, Canada, UK, India, Mexico, and EU comparator markets.
Later
Track pharmacy-level prices, coupons, cash-pay providers, generic availability, and verified substitution boundaries.